Market Trends of France Hospital Supplies Industry
Disposable Hospital Supplies Hold a Significant Share in the Market Studied
Disposable hospital supplies are products designed for one-time use. These products include medical apparatus, consumables, and disposable devices. They are in high demand across all hospitals and are continuously used by hospital professionals, from cleaning to surgical theaters and administrative departments.
The increasing prevalence of hospital-acquired infections is expected to drive the demand for disposable hospital supplies. For example, the highest number of people with sexually transmitted diseases in France has propelled the need for the usage of disposable exam gowns, gloves, and face masks, among others, in the country's hospitals, driving this segment's growth. For instance, according to the UNAIDS data published in 2024, the updated number of HIV patients aged 15 and above in France was 5,900 in 2022.
In addition, the rising awareness of disposable masks to avoid the spread of infections in hospitals is anticipated to drive the market growth over the forecast period. For instance, in January 2024, Renaloo, AIDES, and ELLyE, in collaboration with the French Ministry of Health and Prevention and a consortium, including the National Health Insurance Fund, Santé Publique France, Cespharm, and Uspo, launched the "The Solidarity Mask" campaign. The primary objective of this initiative was to promote mask-wearing to protect the most vulnerable individuals. Therefore, such initiatives may help increase the adoption of disposable masks in hospitals to avoid infections, thereby boosting the segment growth.
The adoption of disposable hospital supplies is continuously growing due to the rising concern for safety and cleanliness against hospital-acquired infections and maintaining hygiene across hospitals.
The Syringes and Needles Segment is Expected to Register a Healthy CAGR During the Forecast Period
The rising incidence of chronic diseases such as diabetes, cancer, and respiratory and cardiovascular diseases in the country is anticipated to increase the adoption of syringes and needles in the treatment of these diseases.
The burden of chronic diseases in France is on the rise, leading to an increase in hospital admissions and demand for medical supplies such as syringes and needles. According to the International Diabetes Federation (IDF), in 2023, the number of patients with diabetes in France is expected to increase from 4,184.9 thousand in 2030 to 4,225.7 thousand by 2045. The expected rise in the burden of chronic diseases such as diabetes is anticipated for syringes and needles in type1 diabetes hospital inpatients, driving the segment growth.
In addition, the number of cancer cases and diagnoses in France is also increasing significantly. According to the Global Cancer Observatory (Globocan) data in February 2024, the number of new cancer cases and five-year prevalence of cancer in the country were 483,568 and 1,494,814 in 2022. This trend is expected to fuel the demand for medical devices such as syringes and needles for the delivery of injectables to cancer patients, thereby contributing to market growth.
Therefore, owing to the rising burden of chronic disorders such as diabetes and cancer, the demand for syringes and needles is expected to increase, thereby driving the segment growth over the forecast period.
